C4 Therapeutics, Inc.

NASDAQ:CCCC

Biotechnology

Healthcare
$2.48 +2.06%

+$0.08 today

Market cap
$325.01M
Beta
2.93
P/E (TTM)
-4.9
EPS (TTM)
-$0.82
52W Low $1.36High $4.60

Volume 2.75M

Average 2.76M

Balance Sheet

Inspect the capital base behind the business.

Assets

$359.07M

FY 2025 · Annual

+2.7% YoY

Liabilities

$102.49M

FY 2025 · Annual

-23.3% YoY

Equity

$256.59M

FY 2025 · Annual

+18.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents76.12M29.75M126.59M55.5M74.6M
Short-term Investments233.16M246.4M127.09M189.41M173.93M
Net Receivables5.72M1.47M11.8M3.1M2.4M
Inventory0(60.96M)000
Other Current Assets070.89M5.71M9.76M7.17M
Total Current Assets325.69M287.56M271.19M257.77M258.11M
Property, Plant & Equipment (Net)35.05M77.52M71.09M63.38M45.28M
Goodwill00000
Intangible Assets00000
Long-term Investments142.2M60.96M28.01M22.36M48.56M
Tax Assets00000
Other Non-current Assets3.82M4.81M6.17M6.1M7.13M
Total Non-current Assets181.08M143.28M105.26M91.84M100.97M
Total Assets506.77M430.84M376.45M349.6M359.08M
Account Payables4.51M1.17M1.45M1.33M858K
Short-term Debt02.29M000
Tax Payables00000
Deferred Revenue31.8M16.62M15.47M18.71M12.49M
Other Current Liabilities5.5M3.11M9.39M9.3M10.06M
Total Current Liabilities51.25M44.55M42.77M45.18M33.03M
Long-term Debt10.77M9.2M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)24.37M16.9M21.81M28.46M15.84M
Other Non-current Liabilities00000
Total Non-current Liabilities65.91M97.06M87.57M88.44M69.46M
Total Liabilities117.16M141.61M130.34M133.62M102.49M
Common Stock5K5K6K7K9K
Retained Earnings(267.72M)(395.89M)(528.38M)(633.7M)(738.69M)
Accumulated OCI(775K)(4.14M)(127K)53K50K
Other Stockholders Equity00000
Minority Interest00000
Total Equity389.61M289.23M246.11M215.99M256.59M
Total Debt42.88M87.15M70.98M65.76M59.98M
Net Debt(33.25M)57.4M(55.61M)10.26M(14.62M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$61.3M
Short-term Investments$174.4M
Receivables$2.9M
Other Current$6.8M
Total Current Assets$245.4M
PP&E (Net)$43.6M
Long-term Investments$36.0M
Other Non-current$3.9M
Total Non-current Assets$83.5M
Total Assets$328.9M

Analysis

Selected assets total $328.9M for Latest. The largest visible component is Short-term Investments at $174.4M, about 53.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

How much cash does CCCC have?

C4 Therapeutics, Inc. (CCCC) reported $74.60M in cash and equivalents in fiscal 2025.

How much debt does CCCC carry?

C4 Therapeutics, Inc. (CCCC) reported $59.98M of total debt, with net debt of -$14.62M.